Business Description
Kukjeon Pharmaceutical Co Ltd
ISIN : KR7307750000
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.93 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.78 | |||||
Debt-to-EBITDA | 4.47 | |||||
Interest Coverage | 0.24 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.81 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.2 | |||||
3-Year Book Growth Rate | 36.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.47 | |||||
9-Day RSI | 39.97 | |||||
14-Day RSI | 41.04 | |||||
6-1 Month Momentum % | -23.41 | |||||
12-1 Month Momentum % | -37.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 0.95 | |||||
Cash Ratio | 0.65 | |||||
Days Inventory | 86.14 | |||||
Days Sales Outstanding | 83.22 | |||||
Days Payable | 47.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.29 | |||||
Dividend Payout Ratio | 0.11 | |||||
Forward Dividend Yield % | 0.29 | |||||
5-Year Yield-on-Cost % | 0.29 | |||||
3-Year Average Share Buyback Ratio | -5.7 | |||||
Shareholder Yield % | -7.04 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 16.73 | |||||
Operating Margin % | 1.44 | |||||
Net Margin % | 4.9 | |||||
FCF Margin % | -0.38 | |||||
ROE % | 6.8 | |||||
ROA % | 2.92 | |||||
ROIC % | 1.36 | |||||
ROC (Joel Greenblatt) % | 12.88 | |||||
ROCE % | 10.02 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 36.84 | |||||
Price-to-Owner-Earnings | 187.85 | |||||
PS Ratio | 1.62 | |||||
PB Ratio | 1.74 | |||||
Price-to-Tangible-Book | 1.79 | |||||
Price-to-Free-Cash-Flow | 311.25 | |||||
Price-to-Operating-Cash-Flow | 16.53 | |||||
EV-to-EBIT | 14.2 | |||||
EV-to-EBITDA | 10.17 | |||||
EV-to-Revenue | 1.3 | |||||
EV-to-FCF | -353.31 | |||||
Earnings Yield (Greenblatt) % | 7.03 | |||||
FCF Yield % | -0.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kukjeon Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 134,440.895 | ||
EPS (TTM) (â‚©) | 95 | ||
Beta | 0.52 | ||
Volatility % | 23.65 | ||
14-Day RSI | 41.04 | ||
14-Day ATR (â‚©) | 161.490414 | ||
20-Day SMA (â‚©) | 3578 | ||
12-1 Month Momentum % | -37.44 | ||
52-Week Range (â‚©) | 3115 - 7090 | ||
Shares Outstanding (Mil) | 49.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kukjeon Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kukjeon Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Kukjeon Pharmaceutical Co Ltd Frequently Asked Questions
What is Kukjeon Pharmaceutical Co Ltd(XKRX:307750)'s stock price today?
When is next earnings date of Kukjeon Pharmaceutical Co Ltd(XKRX:307750)?
Does Kukjeon Pharmaceutical Co Ltd(XKRX:307750) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |